4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026)
4D Molecular Therapeutics' Return on Assets [ROA] was -35.60% in Q2 2026, up 4.05 percentage points from -39.65% a year earlier but down 5.81 percentage points from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at 4D Molecular Therapeutics came in at -24.86%, up 10.87 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of +7.76 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -35.72% in FY2024 (-2.27 pp), -33.46% in FY2023 (+1.47 pp), -34.93% in FY2022 (-12.74 pp) and -22.19% in FY2021 (+10.43 pp).
- Quarterly Return on Assets [ROA] has moved between -46.60% (Q3 2025) and -17.55% (Q2 2024) over five years.
- Compared with a year earlier, Return on Assets [ROA] was higher in four of the last eight quarters, with an average year-over-year change of -5.71 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2024 (a gain of 21.90 percentage points); the worst was Q3 2025 (a drop of 23.17 percentage points).
- Per Business Quant data, FDMT's Return on Assets [ROA] in the three quarters before Q2 2026 was -29.79% (Q1 2026), -28.28% (Q4 2025) and -46.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | 4D Molecular Therapeutics | 1.01 Bn | -454.35 Mn | - | -35.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.60% |
| Mar 31, 2026 | -29.79% |
| Dec 31, 2025 | -28.28% |
| Sep 30, 2025 | -46.60% |
| Jun 30, 2025 | -39.65% |
| Mar 31, 2025 | -32.79% |
| Dec 31, 2024 | -27.62% |
| Sep 30, 2024 | -23.43% |
| Jun 30, 2024 | -17.55% |
| Mar 31, 2024 | -21.53% |
| Dec 31, 2023 | -28.70% |
| Sep 30, 2023 | -26.82% |
| Jun 30, 2023 | -37.34% |
| Mar 31, 2023 | -43.42% |
| Dec 31, 2022 | -39.65% |
| Sep 30, 2022 | -36.07% |
| Jun 30, 2022 | -32.39% |
| Mar 31, 2022 | -23.93% |
| Dec 31, 2021 | -23.97% |
| Sep 30, 2021 | -26.85% |
API Access
4D Molecular Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();